SZodixStudyAcademic Library

Dashboard Shelves Open access My library Inbox Notes Write Learn Alerts

More

Ask your library Notifications Quick cite Review

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Russell P. Rosenberg · Study

Home/Author

Russell P. Rosenberg

13 works· latest 2021· 3 institutionscluster: provisionalORCID 0000-0002-6463-0082

h-index13

i1013

Citations2,449

Works here13

99

04

05

06

08

13

14

17

19

20

21

Most cited in this library

The Sleep and Technology Use of Americans: Findings from the National Sleep Foundation’s 2011 Sleep in America Poll2013 · 497 citations
Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder2019 · 413 citations
Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study2017 · 329 citations
Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials2014 · 301 citations
Zolpidem for Persistent Insomnia in SSRI-Treated Depressed Patients1999 · 176 citations

Works

13 shown

Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies

Neuropsychiatric Disease and Treatment·2021·3 authors·review·Open access

79citations

Safety of lemborexant versus placebo and zolpidem: effects on auditory awakening threshold, postural stability, and cognitive performance in healthy older participants in the middle of the night and upon morning awakening

Journal of Clinical Sleep Medicine·2020·5 authors·Open access

76citations

Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder

JAMA Network Open·2019·9 authors·Open access

413citations

Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study

Journal of Clinical Sleep Medicine·2017·9 authors·Open access

329citations

Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials

Biological Psychiatry·2014·

18 authors

301citations

The Sleep and Technology Use of Americans: Findings from the National Sleep Foundation’s 2011 Sleep in America Poll

Journal of Clinical Sleep Medicine·2013·6 authors·Open access

497citations

Low-Dose Sublingual Zolpidem Tartrate is Associated with Dose-Related Improvement in Sleep Onset and Duration in Insomnia Characterized by Middle-of-the-Night (MOTN) Awakenings

SLEEP·2008·5 authors·Open access

56citations

A polysomnography study of eszopiclone in elderly patients with insomnia

Current Medical Research and Opinion·2006·7 authors

97citations

Sleep Maintenance Insomnia: Strengths and Weaknesses of Current Pharmacologic Therapies

Annals of Clinical Psychiatry·2006·1 author

137citations

A 2-Week Efficacy and Safety Study of Eszopiclone in Elderly Patients with Primary Insomnia

SLEEP·2005·7 authors

143citations

The Efficacy and Safety of the Melatonin Agonist beta-Methyl-6-Chloromelatonin in Primary Insomnia

The Journal of Clinical Psychiatry·2005·6 authors

78citations

An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults

Sleep Medicine·2004·4 authors

67citations

Zolpidem for Persistent Insomnia in SSRI-Treated Depressed Patients

The Journal of Clinical Psychiatry·1999·9 authors

176citations